Givat Shmuel, Israel – March 24, 2010 – Cimatron Limited (Nasdaq: CIMT), a leading provider of integrated CAD/CAM solutions for mold, tool and die makers as well as manufacturers of discrete parts, announced that CimatronE will participate in a special exhibit highlighting its complete solution, that covers full tool design and manufacture, at the Eurostampi tradeshow in Parma, Italy.
Eurostampi’s From Project to Object exhibit will show how a plastic part for the medical industry moves from design to production, with live production of the part on-site. The part is a “Medical Butterfly,” which showcases several clamps used in the medical industry for delivery of plasma, blood, drugs and other fluids. The clamps need to be produced with extremely high standards of accuracy and surface quality in a completely sterile environment.
CimatronE will be the main CAD/CAM software for the project, designing the mold and electrodes, and NC programming all components. First, CimatronE’s QuickSplit will help identify the parting line and create parting surfaces, and then, the full mold tool will be designed. The QuickElectrode solution will automatically extract electrodes from the mold and prepare each electrode for NC programming.
CimatronE will be used to complete NC programming for the entire mold and all of the electrodes. CimatronE’s Micro Milling solution will enable the part to be cut by very small tools, in order to reach the required level of accuracy and provide a superior polish-free surface quality in a short machining time.
From Project to Object: NC programming of the mold in CimatronE (left), the completed mold (center), and the produced part (right).
The exhibit is intended to demonstrate the entire mold making process, showing how different products made by Eurostampi exhibitors work together. CimatronE will be taking mold components from built-in catalogs, in this case Hasco and Meusburger, automatically incorporating components into plates. The mold will be cut on a Makino V33 high speed vertical machining center. The mold maker for this project is Officina Marchetti, a CimatronE customer and leading manufacturer of high production molds for medical equipment and other high precision parts.
Enhancements in the latest version of CimatronE include increased automation for mold design, a quoting application for die design and added flexibility in 5-Axis and High Speed Machining strategies. CimatronE now operates at 64-bits, making full use of available memory and allowing it to handle larger, more complex parts.
Microsystem, Cimatron’s Italian subsidiary, will also showcase the new version of GibbsCAM, Cimatron’s product line for production. GibbsCAM 2010 provides major enhancements for 5-Axis Milling and 3D solids machining, as well as new plunge roughing.
“Eurostampi’s From Project to Object is a great opportunity for visitors to see how technology in general, and CimatronE specifically, can offer serious advantages in terms of shortening delivery times and reaching the stringent quality requirements of the medical industry,” said Gianluca Renzi, CTO of Microsystem.
Eurostampi will take place at the Parma Fairground in Italy from March 25th-27th. Microsystem’s booth will be located in hall 9, booth K5.
With over 25 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time.
The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.
Cimatron's shares are publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit the company's website at: http://www.cimatron.com/
This press release includes forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to the Company’s plans, objectives and expected financial and operating results. The words "may," "could," "would," “will,” "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of the Company's future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycle, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to the Company’s filings with the Securities and Exchange Commission. The Company cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
For More Information Contact:
Idit Pass Lagziel
Phone: +972 3 5312098
Chief Financial Officer
Phone: +972 3 531 2121